Alterity Therapeutics

(NASDAQ) ATHE

Current Price$4.36

Market Cap$1.53M

Since IPO (2002)-99%

5 Year-70%

1 Year-8%

1 Month-9%

Alterity Therapeutics Financials at a Glance

Market Cap

$1.53M

Revenue (TTM)

A$7.56M

Net Income (TTM)

-A$34.20M

EPS (TTM)

-$28.95

P/E Ratio

-0.15

Dividend

$0.00

Beta (Volatility)

0.69 (Low)

Dividend

$0.00

Beta (Volatility)

0.69 (Low)

Price

$4.36

Volume

318

Open

$4.40

Price

$4.36

Volume

318

Open

$4.40

Previous Close

$4.36

Daily Range

$4.36 - $4.40

52-Week Range

$2.66 - $7.00

Estimated Earnings Date

Aug 28, 2026

Dividend

$0.00

Beta (Volatility)

0.69 (Low)

Price

$4.36

Volume

318

Open

$4.40

Previous Close

$4.36

Daily Range

$4.36 - $4.40

52-Week Range

$2.66 - $7.00

Estimated Earnings Date

Aug 28, 2026

ATHE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Alterity Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

David A. Stamler, MD

Website

www.alteritytherapeutics.com

Headquarters

Melbourne, VIC 3000, AU

ATHE Financials

Key Financial Metrics (TTM)

Gross Margin

97%

Operating Margin

-5%

Net Income Margin

-4%

Return on Equity

-46%

Return on Capital

-37%

Return on Assets

-26%

Earnings Yield

-6.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.53M

Shares Outstanding

362.50K

Volume

318

Avg. Volume

46.12K

Financials (TTM)

Gross Profit

A$5.31M

Operating Income

-A$14.57M

EBITDA

-A$14.63M

Operating Cash Flow

-A$11.45M

Capital Expenditure

A$3.00

Free Cash Flow

-A$11.45M

Cash & ST Invst.

A$40.66M

Total Debt

A$155.46K

Alterity Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

A$0.00

-100.0%

Gross Profit

-A$56.83K

-103.1%

Gross Margin

0.00%

N/A

Market Cap

$1.53M

N/A

Market Cap/Employee

$152.62K

N/A

Employees

N/A

Net Income

-A$9.44M

-45.1%

EBITDA

-A$12.76M

-53.1%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

A$49.15M

+298.9%

Total Debt

A$98.35K

-61.5%

Accounts Receivable

A$6.84M

+17.7%

Inventory

A$0.00

N/A

Long Term Debt

A$65.40K

-14.5%

Short Term Debt

A$32.96K

-81.6%

Return on Assets

-25.63%

N/A

Return on Invested Capital

-37.08%

N/A

Free Cash Flow

A$0.00

+100.0%

Operating Cash Flow

-A$10.43M

-131.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LIMNLiminatus Pharma, Inc. Class A Common Stock

LIMNLiminatus Pharma, Inc. Class A Common Stock$0.12-10.29%

EVAXEvaxion Biotech A/S

EVAXEvaxion Biotech A/S$3.64+0.83%

DYAIDyadic International, Inc.

DYAIDyadic International, Inc.$0.68-0.04%

ANVSAnnovis Bio, Inc.

ANVSAnnovis Bio, Inc.$1.78-2.73%

BTAIBioXcel Therapeutics, Inc.

BTAIBioXcel Therapeutics, Inc.$1.14+2.70%

MURAMural Oncology plc

MURAMural Oncology plc$2.04+0.00%

GBIOGeneration Bio Co.

GBIOGeneration Bio Co.$5.34+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$160.95+0.19%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

RKLBRocket Lab

RKLBRocket Lab$102.39-0.11%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

Questions About ATHE

What is the current price of Alterity Therapeutics?

Alterity Therapeutics is trading at $4.36 per share.

What is the 52-week range for Alterity Therapeutics?

Over the past 52 weeks, Alterity Therapeutics has traded between $2.66 and $7.00.

How much debt does Alterity Therapeutics have?

As of the most recent reporting period, Alterity Therapeutics reported total debt of A$101.88K.

How much cash does Alterity Therapeutics have on hand?

Alterity Therapeutics reported A$21.73M in cash and cash equivalents in its most recent financial results.

What is Alterity Therapeutics’s dividend yield?

Alterity Therapeutics does not currently have a dividend yield.

Alterity Therapeutics

Alterity Therapeutics Financials at a Glance

ATHE News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Alterity Therapeutics

ATHE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Alterity Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ATHE

What is the current price of Alterity Therapeutics?

What is the 52-week range for Alterity Therapeutics?

How much debt does Alterity Therapeutics have?

How much cash does Alterity Therapeutics have on hand?

What is Alterity Therapeutics’s dividend yield?

Premium Investing Services